Nikhil Lalwani

Nikhil Lalwani

Chief Executive Officer at ANI PHARMACEUTICALS, INC.

Net worth: 29 M $ as of 30/06/2026

48 year
Health Technology
Consumer Services
Commercial Services

Profile

Nikhil Lalwani is President, Chief Executive Officer & Director at ANI Pharmaceuticals, Inc. since 2020.
Formerly, Chief Executive Officer-India RX Business at Cipla Ltd. in 2020.
Chief Executive Officer at InvaGen Pharmaceuticals, Inc. from 2016 to 2020.
Chief Executive Officer at Cipla USA, Inc. from 2016 to 2020.
Associate Partner at McKinsey & Co., Inc. Education includes undergraduate studies at Georgia Institute of Technology and both undergraduate and MBA degrees from The Wharton School of the University of Pennsylvania.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
11/05/2026 349,889 ( 1.54% ) 29 M $ 30/06/2026

Nikhil Lalwani active positions

CompaniesPositionStart
ANI PHARMACEUTICALS, INC. Chief Executive Officer 08/09/2020

Former positions of Nikhil Lalwani

CompaniesPositionEnd
CIPLA LIMITED Corporate Officer/Principal 01/08/2020
Chief Executive Officer 01/04/2020
Chief Executive Officer 01/04/2020
Corporate Officer/Principal -
See the detail of Nikhil Lalwani's experience

Training of Nikhil Lalwani

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

6

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Commercial Services

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Nikhil Lalwani